Canrenoic acid potassium salt
SIGMA/C7287 - powder
Synonym: 17-
CAS Number: 2181-04-6
Empirical Formula (Hill Notation): C22H30KO4
Molecular Weight: 397.57
EC Number: 218-554-9
MDL Number: MFCD05662375
Linear Formula: C22H30O4K
Product Type: Chemical
| color | light yellow to tan |
| form | powder |
| InChI | 1S/C22H30O4.K.H/c1-20-9-5 |
| InChI key | YLXFIHIYNGPPSF-HUHWECDNSA |
| Quality Level | 100 ![]() |
| SMILES string | [K].[H][C@]12CC[C@@]3(C)[ |
| Analysis Note: | Aqueous solutions may contain some insoluble material. |
| Application: | Canrenoic acid potassium salt has been used as a human uridine 5′-diphospho (UDP)-glucuronosyltransfe |
| Biochem/physiol Actions: | Competitive aldosterone receptor antagonist. |
| Biochem/physiol Actions: | Competitive aldosterone receptor antagonist. Potassium canrenoate reduces the effects of aldosterone-induced increases in blood pressure and in cardiovascular fibrosis in animals with high sodium intake. It is used clinically for its anti-fibrotic effects. At higher doses it is genotoxic to liver and increases tumor incidence in rodent models. |
| Packaging: | 5 g in poly bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| UNSPSC | 12352106 |


